Bio-Techne
TECH
#1525
Rank
A$17.41 B
Marketcap
$109.60
Share price
0.32%
Change (1 day)
12.79%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : A$0.61 Billion

According to Bio-Techne's latest financial reports the company's total debt is A$0.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30A$0.68 B45.07%
2022-06-30A$0.47 B-15.36%
2021-06-30A$0.55 B-11.28%
2020-06-30A$0.63 B-12.31%
2019-06-30A$0.71 B57.1%
2018-06-30A$0.45 B2.37%
2017-06-30A$0.44 B250.77%
2016-06-30A$0.12 B27.03%
2015-06-30A$0.10 B630.22%
2014-06-30A$13.74 M
2006-06-30A$18.07 M-5.63%
2005-06-30A$19.15 M-16.57%
2004-06-30A$22.95 M-10.26%
2003-06-30A$25.58 M-20.44%
2002-06-30A$32.15 M-13.09%
2001-06-30A$37 M12.54%
2000-06-30A$32.87 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
A$54.29 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.13 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
A$29.71 B 4,743.85%๐Ÿ‡บ๐Ÿ‡ธ USA
A$26.94 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.15 B 251.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$30.63 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.39 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA